A detailed history of Jane Street Group, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 24,958 shares of AURA stock, worth $228,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,958
Previous 64,541 61.33%
Holding current value
$228,116
Previous $487,000 54.41%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.9 - $10.36 $273,122 - $410,079
-39,583 Reduced 61.33%
24,958 $222,000
Q2 2024

Aug 14, 2024

BUY
$6.81 - $7.89 $296,364 - $343,364
43,519 Added 207.02%
64,541 $487,000
Q1 2024

May 15, 2024

SELL
$7.09 - $9.24 $55,053 - $71,748
-7,765 Reduced 26.97%
21,022 $165,000
Q4 2023

Feb 14, 2024

BUY
$7.02 - $11.98 $202,084 - $344,868
28,787 New
28,787 $255,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $268M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.